{"database": "openregs", "table": "documents", "rows": [["FDA-1980-N-0038-0140", "FDA", "FDA-1980-N-0038", "Certain Topical Anti-Infective Drug Products; Vioform-Hydrocortisone (Iodochlorhydroxyquin and Hydrocortisone) Request of CIBA-GEIGY Corporation for Hearing Vol II re: Supplement from CIBA-GEIGY (Wald, Harkrader & Ross) (Vol. 3 of 3)", "Supporting & Related Material", "Background Material", "2017-12-28T05:00:00Z", 2017, 12, null, null, "2017-12-28T18:12:50Z", null, 0, 0, "0900006482ceabb3"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1980-N-0038-0140"], "units": {}, "query_ms": 37.91614808142185, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}